Ashish P.S. Bains

Ashish P.S. Bains, MD, is a Professor in the Department of Clinical Pathology & Laboratory Medicine at the Lewis Katz School of Medicine, Temple University, and serves as the Director of Hematopathology at Temple University Hospital. He specializes in hematologic pathology, with a focus on neoplastic molecular pathology and the molecular basis of hematologic malignancies.

• Education: MD from Maulana Azad Medical College, Delhi University, India; Residency in Pathology at Oklahoma University Health Sciences Center; Fellowships in Hematopathology (NYU Langone Medical Center) and Molecular Genetics Pathology (MD Anderson Cancer Center).
• Board Certifications: American Board of Pathology in Anatomic Pathology, Hematopathology, and Molecular Genetic Pathology.
• Professional Membership: American Society for Clinical Pathology.

Dr. Bains' research is centered on understanding the molecular mechanisms underlying hematologic cancers, particularly through mutation profiling in acute myeloid leukemia, myelodysplastic syndromes, and lymphoid neoplasms. His clinical and scholarly work bridges diagnostic pathology with molecular genetics to improve cancer classification and patient outcomes.

His recent publications (2011–2024) reflect a consistent focus on rare and complex hematologic disorders, including lymphomas with novel genetic fusions (e.g., PABPC1::ALK), hemophagocytic lymphohistiocytosis, and diagnostic challenges in CNS and oral cavity lymphomas. His work frequently involves clinicopathologic correlation and advanced molecular techniques.

• ALK-positive large B-cell lymphoma with epithelial antigen expression
• Molecular characterization of AML with trisomy 4
• TET2 mutations in PNH
• Plasmablastic lymphomas of the oral cavity

Dr. Bains has contributed to high-impact journals such as Am J Clin Pathol, Exp Hematol Oncol, Am J Surg Pathol, and Chest. His work demonstrates a strong commitment to advancing diagnostic precision in hematopathology.

He has held advisory roles in clinical case publications and collaborates with multidisciplinary teams at Temple University Hospital. There is no mention of formal PhD or master’s students, but his leadership in hematopathology suggests mentorship of trainees and fellows. He is actively involved in both clinical service and research, with no indication of retirement or part-time status.